Exam Focusmolecular biology

One Gene, One Enzyme: From Genes to Traits

Overview

In the 1940s, experiments with bread mold showed that genes work by specifying enzymes — each mutation knocking out one step of a metabolic pathway. This lesson traces the one-gene–one-enzyme hypothesis, its experimental logic, and its modern refinement, connecting the genotype-to-phenotype path that underlies all of genetics.

Learning objectives

  • Describe the Beadle and Tatum experimental approach with Neurospora.
  • Explain how auxotrophic mutants revealed pathway steps.
  • State the one-gene–one-enzyme hypothesis.
  • Explain its refinement to one gene–one polypeptide.
  • Connect the hypothesis to the genotype-phenotype relationship.

The question: what do genes actually do?

By the 1940s, genetics could map genes to chromosomes but could not say what a gene was for. The hypothesis under test was concrete: genes act by directing the synthesis of enzymes, so each gene controls one chemical step. Testing it required an organism where mutations could be linked to missing chemistry — and bread mold provided it.

The Neurospora experiments

Researchers irradiated the bread mold Neurospora, then screened for mutants that could no longer grow on minimal medium but could grow when a specific nutrient — such as the amino acid arginine — was added. These auxotrophic mutants were then tested on media supplemented with each intermediate of the arginine pathway. A mutant rescued only by the final product was blocked at the last step; one rescued by a middle intermediate was blocked earlier. Each mutation disabled exactly one enzyme in the pathway.

The experimental logic

Mutant grows on minimal medium plus intermediate X but not on earlier intermediates → the block lies just before X. Supplementation maps the broken step.

The hypothesis

The pattern was striking: one mutation, one blocked reaction, one missing enzyme. The conclusion drawn was the one-gene–one-enzyme hypothesis — each gene directs the production of a single enzyme, and the gene's effect on the organism flows through that enzyme's chemistry. It was the first precise statement of how genotypes become phenotypes.

Refinement: one gene, one polypeptide

Later work refined the idea. Some proteins contain multiple polypeptide chains encoded by separate genes, and some genes encode non-enzyme proteins like hemoglobin or non-coding RNAs. The modern statement is one gene–one polypeptide: a gene's primary job is specifying an amino-acid sequence, and enzymes are the most common — but not the only — product.

Why it still appears on exams

The hypothesis is the historical bridge between Mendelian genetics and molecular biology — exam questions use it to test whether you can connect mutation to pathway block to phenotype.

Legacy in modern biology

The logic outlived the slogan. Metabolic pathway analysis, newborn screening for enzyme deficiencies, and the interpretation of genetic diseases all rest on the same chain: mutation → altered polypeptide → altered chemistry → phenotype. Phenylketonuria, for example, is one broken enzyme in phenylalanine metabolism producing systemic effects — one gene, one enzyme, one disease, exactly as the hypothesis framed it.

Key points

  • Genes were first linked to function through enzymes they specify.
  • Neurospora auxotrophs mapped mutations to single blocked pathway steps.
  • One mutation → one missing enzyme → one blocked reaction.
  • Modern form: one gene specifies one polypeptide.
  • The mutation→polypeptide→chemistry→phenotype chain underlies genetic disease logic.

Common misconceptions

✗ Myth: One gene always equals one enzyme, literally.

✓ Truth: The refined version is one gene–one polypeptide: genes also encode structural proteins and RNAs, and multi-subunit proteins need several genes.

✗ Myth: Beadle and Tatum discovered what genes are made of.

✓ Truth: They revealed what genes do — specify enzymes — working years before DNA's structure was known.

Practice questions

Q1. A Neurospora mutant grows on minimal medium plus citrulline but not plus ornithine (an earlier intermediate). The mutation most likely affects the enzyme that converts:
  1. arginine to citrulline
  2. ornithine to citrulline
  3. citrulline to arginine
  4. nothing; it is unrelated
Answer: B.

Growth on citrulline but not on the earlier ornithine places the block between them — the enzyme converting ornithine to citrulline is defective.

Q2. The modern refinement of one-gene–one-enzyme is one-gene–one-polypeptide because:
  1. enzymes don't exist
  2. some proteins have multiple polypeptide chains from different genes
  3. genes are made of protein
  4. polypeptides are not encoded
Answer: B.

Multi-subunit proteins and non-enzyme gene products showed the gene's direct product is a polypeptide chain, not necessarily a complete enzyme.

Q3. The one-gene–one-enzyme hypothesis was historically important because it:
  1. described DNA structure
  2. first connected genes to specific biochemical functions
  3. discovered mutation
  4. explained natural selection
Answer: B.

It gave genetics a biochemical mechanism — genes specify enzymes — bridging Mendel's factors and molecular biology.

Click a question to reveal the answer and explanation.

Frequently asked questions

What did the Neurospora experiments show?

That irradiating bread mold produced mutants each unable to make a specific nutrient, and supplementation tests showed each mutant was blocked at exactly one enzymatic step of a metabolic pathway.

How did adding intermediates identify the blocked step?

If a mutant grows when given intermediate X but not earlier intermediates, its defective enzyme must act just before X in the pathway — later steps are intact, earlier ones irrelevant.

Why was the hypothesis revised to one gene–one polypeptide?

Because some functional proteins are built from multiple polypeptides encoded by different genes, and some genes encode structural proteins or RNAs rather than enzymes.

How does this hypothesis explain genetic diseases?

A mutation alters one polypeptide, breaking one chemical step; the metabolic block then produces the disease phenotype — as in PKU, where one defective enzyme disrupts phenylalanine metabolism.